Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 80Glioma 70Glioblastoma 70Neuroblastoma 27Neoplasms 20Neurofibromatosis 1 19Astrocytoma 18Sarcoma 17Ependymoma 17Central Nervous System Neoplasms 17Medulloblastoma 16Melanoma 15Meningioma 14Carcinoma, Non-Small-Cell Lung 14Rhabdoid Tumor 13Osteosarcoma 13Wilms Tumor 12Sarcoma, Ewing 12Rhabdomyosarcoma 12Neurofibroma, Plexiform 11Hepatoblastoma 11Breast Neoplasms 11Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Non-Hodgkin 9Histiocytosis, Langerhans-Cell 9Pancreatic Neoplasms 8Diffuse Intrinsic Pontine Glioma 8Colorectal Neoplasms 8Carcinoma, Hepatocellular 8Thyroid Neoplasms 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Legius syndrome × CNS × 30 days × Clear all
NCT00111384 2026-06-05

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

National Institutes of Health Clinical Center (CC)

Completed
313 enrolled
CNS

Legius syndrome, Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡